Maxim Group Starts Biocept (BIOC) at Buy

March 26, 2019 7:37 AM

Maxim Group analyst Jason McCarthy initiates coverage on Biocept (NASDAQ: BIOC) with a Buy rating and a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found